1. An oil brake driving device, comprising:
a main body, having a front end with an enclosed space and a rear end with a rear opening which is connected with said enclosed space;
an expansion piece, placed in said enclosed space and having a pressure chamber and an opening; and
a connecting head, having a channel and a front end that is connected with said opening of said expansion piece and being fastened on said rear opening of said main body.
2. The oil brake driving device according to claim 1, wherein said connecting head and said expansion piece are integrated into a single body.
3. The oil brake driving device according to claim 1, wherein said connecting head and said expansion piece are fastened to said main body by screws.
4. The oil brake driving device according to claim 1, wherein said expansion piece has a front side on which a piston is set.
5. The oil brake driving device according to claim 4, wherein said piston carries a caliper.
6. The oil brake driving device according to claim 4, wherein said piston has a cross-section shaped like the letter H.
7. The oil brake driving device according to claim 4, wherein said piston has a cross-section shaped like the letter U.
8. The oil brake driving device according to claim 1, wherein said expansion piece has a periphery with bellows.
9. An oil brake driving device, comprising:
a main body, having a front end and an enclosed space;
an expansion piece, placed in said front end of said main body and having a rear side;
a pressure plate, attached to said rear side of said expansion piece and having a hole; and
a connecting head, having a channel and a front end that is connected with said expansion piece and being fastened on said hole of said pressing plate.
10. The oil brake driving device according to claim 9, wherein said expansion piece has a pressure chamber.
11. The oil brake driving device according to claim 9, wherein said expansion piece has a front side on which a piston is set.
12. The oil brake driving device according to claim 10, wherein said piston carries a caliper.
13. The oil brake driving device according to claim 10, wherein said piston has a cross-section shaped like the letter H.
14. The oil brake driving device according to claim 10, wherein said piston has a cross-section shaped like the letter U.
15. The oil brake driving device according to claim 9, wherein said expansion piece has a periphery with bellows.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1-22. (canceled)
23. A method for inhibiting in vivo synthesis of a PI3 kinase-dependent inflammatory cytokine in a vertebrate, comprising a step of administering Li ion to the vertebrate.
24. The method of claim 23, wherein the cytokine is IL-12.
25. The method of claim 23, wherein the Li ion is administered by injection or oral administration.
26. A method for suppressing cell-mediated immune responses in a vertebrate, comprising a step of administering Li ion to the vertebrate.
27. The method of claim 26, wherein the Li ion is administered by injection or oral administration.
28. A method for activating humoral immune responses in a vertebrate, comprising a step of administering Li ion to the vertebrate.
29. The method of claim 28, wherein the Li ion is administered by injection or oral administration.
30. A therapeutic method for treating a disease resulting from synthesis of a PI3 kinase-dependent inflammatory cytokine, comprising a step of administering Li ion to the vertebrate.
31. The therapeutic method of claim 30, wherein the cytokine is IL-12.
32. The therapeutic method of claim 31, wherein the Li ion is administered by injection or oral administration.
33. A therapeutic method for a disease resulting from an increase in the ratio of a cell-mediated immune response to a humoral immune response, comprising a step of administering Li ion to the vertebrate.
34. The therapeutic method of claim 33, wherein the disease is a disorder resulting from proliferation of pathogenic E. coli, an immune-mediated inflammatory disorder (IMID), a habitual miscarriage, an organ-specific autoimmune disease based on delayed type hypersensitivity, a hepatic disorder, or arteriosclerosis.
35. The therapeutic method of claim 33, wherein the Li ion is administered by injection or oral administration.
36. A method for suppressing in vivo proliferation of pathogenic E. coli in a vertebrate, comprising a step of administering Li ion to the vertebrate.
37. The method of claim 36, wherein the Li ion is administered by injection or oral administration.